Lumexa Imaging Holdings, Inc. (LMRI)
NASDAQ: LMRI · Real-Time Price · USD
8.94
-0.41 (-4.39%)
Apr 6, 2026, 4:00 PM EDT - Market closed

Lumexa Imaging Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
1,023948.87935.93
Revenue Growth (YoY)
7.82%1.38%-
Cost of Revenue
865.52852.61836.96
Gross Profit
157.5796.2698.97
Selling, General & Admin
65.6148.7648.22
Operating Expenses
105.9890.92104.85
Operating Income
51.585.34-5.88
Interest Expense
-118.54-136.03-141.69
Earnings From Equity Investments
72.1471.5155.53
EBT Excluding Unusual Items
5.18-59.18-92.05
Merger & Restructuring Charges
-21.33-18.17-4.01
Impairment of Goodwill
---18.97
Gain (Loss) on Sale of Assets
-0.972.29-1.29
Other Unusual Items
-16.98-4.14-2.93
Pretax Income
-32.22-79.19-119.25
Income Tax Expense
14.8914.912.98
Net Income
-47.1-94.1-122.23
Net Income to Common
-47.1-94.1-122.23
Shares Outstanding (Basic)
716969
Shares Outstanding (Diluted)
716969
Shares Change (YoY)
2.17%0.08%-
EPS (Basic)
-0.66-1.35-1.76
EPS (Diluted)
-0.66-1.35-1.76
Free Cash Flow
-6.412.9513.51
Free Cash Flow Per Share
-0.090.190.20
Gross Margin
15.40%10.14%10.57%
Operating Margin
5.04%0.56%-0.63%
Profit Margin
-4.60%-9.92%-13.06%
Free Cash Flow Margin
-0.63%1.36%1.44%
EBITDA
91.9647.5150.75
EBITDA Margin
8.99%5.01%5.42%
D&A For EBITDA
40.3842.1656.63
EBIT
51.585.34-5.88
EBIT Margin
5.04%0.56%-0.63%
Revenue as Reported
1,023948.87935.93
Updated Mar 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q